Christian Hampp,
Affiliate Faculty
Department:
Pharmaceutical Outcomes & Policy
Business Phone:
(352) 273-6248
Business Email:
champp@ufl.edu
Teaching Profile
Courses Taught
2010,2018-2019
PHA6935 Selected Topics in Pharmacy
2012-2015,2018-2019
PHA6891 Introduction to Pharmacoepidemiology
Publications
Academic Articles
2025
Balancing the Scales: Optimizing Reporting of Infection Rates in Clinical Trials of Bispecific Antibodies in Multiple Myeloma.
American journal of hematology.
100(4):548-551
[DOI] 10.1002/ajh.27618.
[PMID] 39887567.
2023
Adaptability of High Dimensional Propensity Score Procedure in the Transition from ICD-9 to ICD-10 in the US Healthcare System.
Clinical epidemiology.
15:645-660
[DOI] 10.2147/CLEP.S405165.
[PMID] 37274833.
2023
Assessment of the Risk Evaluation and Mitigation Strategy (REMS) for Phentermine-Topiramate to Prevent Exposure During Pregnancy.
Annals of internal medicine.
176(4):443-454
[DOI] 10.7326/M22-1743.
[PMID] 36940443.
2022
Topiramate Utilization After Phentermine/Topiramate Approval for Obesity Management: Risk Minimization in the Era of Drug Repurposing.
Drug safety.
45(12):1517-1527
[DOI] 10.1007/s40264-022-01244-6.
[PMID] 36318419.
2022
Utilization of chronic lung disease treatment before the respiratory syncytial virus season as palivizumab prophylaxis qualifier in the American Academy of Pediatrics Guidelines.
European journal of pediatrics.
181(2):841-845
[DOI] 10.1007/s00431-021-04233-6.
[PMID] 34365543.
2021
Calibration of Chronic Lung Disease Severity as a Risk Factor for Respiratory Syncytial Virus Hospitalization.
Journal of the Pediatric Infectious Diseases Society.
10(3):317-325
[DOI] 10.1093/jpids/piaa107.
[PMID] 32978942.
2020
Cancer Risk Associated with Lorcaserin – The FDA’s Review of the CAMELLIA-TIMI 61 Trial.
The New England journal of medicine.
383(11):1000-1002
[DOI] 10.1056/NEJMp2003873.
[PMID] 32905671.
2020
Data linkage in pharmacoepidemiology: A call for rigorous evaluation and reporting.
Pharmacoepidemiology and drug safety.
29(1):9-17
[DOI] 10.1002/pds.4924.
[PMID] 31736248.
2020
Erratum. Use of Sodium-Glucose Cotransporter 2 Inhibitors in Patients With Type 1 Diabetes and Rates of Diabetic Ketoacidosis. Diabetes Care 2020;43:90-97.
Diabetes care.
43(9)
[DOI] 10.2337/dc20-er09a.
[PMID] 32647048.
2020
The Role of Unit-Dose Child-Resistant Packaging in Unintentional Childhood Exposures to Buprenorphine-Naloxone Tablets.
Drug safety.
43(2):189-191
[DOI] 10.1007/s40264-019-00883-6.
[PMID] 31745829.
2020
Usability of encounter data for Medicaid comprehensive managed care vs traditional Medicaid fee-for-service claims among pregnant women.
Pharmacoepidemiology and drug safety.
29(1):30-38
[DOI] 10.1002/pds.4923.
[PMID] 31737976.
2020
Use of Sodium-Glucose Cotransporter 2 Inhibitors in Patients With Type 1 Diabetes and Rates of Diabetic Ketoacidosis.
Diabetes care.
43(1):90-97
[DOI] 10.2337/dc19-1481.
[PMID] 31601640.
2020
Validation of algorithms to estimate gestational age at birth in the Medicaid Analytic eXtract-Quantifying the misclassification of maternal drug exposure during pregnancy.
Pharmacoepidemiology and drug safety.
29(11):1414-1422
[DOI] 10.1002/pds.5126.
[PMID] 32909348.
2019
Evaluation of the US Food and Drug Administration Sentinel Analysis Tools Using a Comparator with a Different Indication: Comparing the Rates of Gastrointestinal Bleeding in Warfarin and Statin Users.
Pharmaceutical medicine.
33(1):29-43
[DOI] 10.1007/s40290-018-00265-w.
[PMID] 31933271.
2019
Misclassification in Assessment of First Trimester In-utero Exposure to Drugs Used Proximally to Conception: the Example of Letrozole Utilization for Infertility Treatment.
American journal of epidemiology.
188(2):418-425
[DOI] 10.1093/aje/kwy237.
[PMID] 30321259.
2019
Validation of mother-infant linkage using Medicaid Case ID variable within the Medicaid Analytic eXtract (MAX) database.
Pharmacoepidemiology and drug safety.
28(9):1222-1230
[DOI] 10.1002/pds.4843.
[PMID] 31286606.
2018
Enrollment and Retention in 34 United States Pregnancy Registries Contrasted with the Manufacturer’s Capture of Spontaneous Reports for Exposed Pregnancies.
Drug safety.
41(1):87-94
[DOI] 10.1007/s40264-017-0591-5.
[PMID] 28840499.
2018
Prospective Postmarketing Surveillance of Acute Myocardial Infarction in New Users of Saxagliptin: A Population-Based Study.
Diabetes care.
41(1):39-48
[DOI] 10.2337/dc17-0476.
[PMID] 29122893.
2018
Safety assessment of niacin in the US Food and Drug Administration’s mini-sentinel system.
Pharmacoepidemiology and drug safety.
27(1):30-37
[DOI] 10.1002/pds.4343.
[PMID] 29108128.
2018
Utilization of drugs with pregnancy exposure registries during pregnancy.
Pharmacoepidemiology and drug safety.
27(6):604-611
[DOI] 10.1002/pds.4409.
[PMID] 29516585.
2017
A systematic review of pregnancy exposure registries: examination of protocol-specified pregnancy outcomes, target sample size, and comparator selection.
Pharmacoepidemiology and drug safety.
26(2):208-214
[DOI] 10.1002/pds.4150.
[PMID] 28028914.
2017
Pioglitazone and bladder cancer: FDA’s assessment.
Pharmacoepidemiology and drug safety.
26(2):117-118
[DOI] 10.1002/pds.4154.
[PMID] 28067434.
2017
Recommendations on the use and nonuse of the p value in biomedical research.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
74(16):1262-1266
[DOI] 10.2146/ajhp160443.
[PMID] 28790078.
2017
Sentinel Modular Program for Propensity Score-Matched Cohort Analyses: Application to Glyburide, Glipizide, and Serious Hypoglycemia.
Epidemiology (Cambridge, Mass.).
28(6):838-846
[DOI] 10.1097/EDE.0000000000000709.
[PMID] 28682851.
2016
Notes from the Field: Pediatric Emergency Department Visits for Buprenorphine/Naloxone Ingestion – United States, 2008-2015.
MMWR. Morbidity and mortality weekly report.
65(41):1148-1149
[DOI] 10.15585/mmwr.mm6541a5.
[PMID] 27764078.
2016
Risk for Hospitalized Heart Failure Among New Users of Saxagliptin, Sitagliptin, and Other Antihyperglycemic Drugs: A Retrospective Cohort Study.
Annals of internal medicine.
164(11):705-14
[DOI] 10.7326/M15-2568.
[PMID] 27110660.
2016
Use of Prescription Drug Samples in the USA: A Descriptive Study with Considerations for Pharmacoepidemiology.
Drug safety.
39(3):261-70
[DOI] 10.1007/s40264-015-0382-9.
[PMID] 26798052.
2015
Editorial Commentary: Can a Reduced-Dose Prophylaxis Schedule Provide Adequate Coverage Against Respiratory Syncytial Virus Infection?
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
61(4):515-6
[DOI] 10.1093/cid/civ336.
[PMID] 25904371.
2015
Patient understanding of drug risks: an evaluation of medication guide assessments.
Pharmacoepidemiology and drug safety.
24(5):518-25
[DOI] 10.1002/pds.3762.
[PMID] 25808393.
2014
Emergency hospitalizations for unsupervised prescription medication ingestions by young children.
Pediatrics.
134(4):e1009-16
[DOI] 10.1542/peds.2014-0840.
[PMID] 25225137.
2014
Use of antidiabetic drugs in the U.S., 2003-2012.
Diabetes care.
37(5):1367-74
[DOI] 10.2337/dc13-2289.
[PMID] 24623020.
2013
Appropriateness of age thresholds for respiratory syncytial virus immunoprophylaxis in moderate-preterm infants: a cohort study.
JAMA pediatrics.
167(12):1118-24
[DOI] 10.1001/jamapediatrics.2013.2636.
[PMID] 24126903.
2013
Prevalence, trends, and patterns of use of antidiabetic medications among pregnant women, 2001-2007.
Obstetrics and gynecology.
121(1):106-14
[DOI] http://10.1097/AOG.0b013e318278ce86.
[PMID] 23262934.
2013
Use of prescription antiobesity drugs in the United States.
Pharmacotherapy.
33(12):1299-307
[DOI] 10.1002/phar.1342.
[PMID] 24019195.
2013
Validity of laboratory-based surveillance for detection of respiratory syncytial virus seasons.
American journal of epidemiology.
177(8):841-51
[DOI] 10.1093/aje/kws304.
[PMID] 23479344.
2012
An algorithm to identify preterm infants in administrative claims data.
Pharmacoepidemiology and drug safety.
21(6):640-50
[DOI] 10.1002/pds.3264.
[PMID] 22504840.
2012
Effectiveness of palivizumab prophylaxis in infants and children in Florida.
Pharmacoepidemiology and drug safety.
21(1):53-60
[DOI] 10.1002/pds.2246.
[PMID] 21919115.
2012
Feasibility of short-term infusion of magnesium sulfate in pediatric patients with status asthmaticus.
The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG.
17(2):150-4
[DOI] 10.5863/1551-6776-17.2.150.
[PMID] 23118666.
2012
Methodological Concerns Regarding Cost-effectiveness Analysis of Palivizumab in Florida Medicaid-Reply.
Archives of pediatrics & adolescent medicine.
166(10):968-70
[DOI] 10.1001/archpediatrics.2012.1594.
[PMID] 23753905.
2011
Age-Dependent Effectiveness of Rsv Immunoprophylaxis
Pharmacoepidemiology and Drug Safety.
20
2011
Appropriateness of Age Thresholds for Palivizumab Prophylaxis in Preterm Infants
Pharmacoepidemiology and Drug Safety.
20
2011
Cost-effectiveness of respiratory syncytial virus prophylaxis in various indications.
Archives of pediatrics & adolescent medicine.
165(6):498-505
[DOI] 10.1001/archpediatrics.2010.298.
[PMID] 21300647.
2011
Invasive fungal infections in lung transplant recipients not receiving routine systemic antifungal prophylaxis: 12-year experience at a university lung transplant center.
Pharmacotherapy.
31(6):537-45
[DOI] 10.1592/phco.31.6.537.
[PMID] 21923437.
2011
Longitudinal study of optic cup progression in children.
Journal of pediatric ophthalmology and strabismus.
48(3):151-6
[DOI] 10.3928/01913913-20100719-06.
[PMID] 20669878.
2011
Review of a large clinical series: once- versus twice-daily enoxaparin for venous thromboembolism prophylaxis in high-risk trauma patients.
Journal of intensive care medicine.
26(2):111-5
[DOI] 10.1177/0885066610384462.
[PMID] 21257630.
2010
Comparison of Rsv Seasonality in Four States
American Journal of Epidemiology.
171
2010
Latitude as a Factor in Rsv Epidemiology in Florida
American Journal of Epidemiology.
171
2010
Palivizumab utilization and compliance: trends in respiratory syncytial virus prophylaxis in Florida.
The Journal of pediatrics.
156(6):953-959.e1
[DOI] 10.1016/j.jpeds.2009.12.016.
[PMID] 20223478.
2010
Root cause analysis and subsequent intervention to improve first dose antibiotic turnaround time for hospitalized pediatric patients.
The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG.
15(3):182-8
[PMID] 22477810.
2010
Small budget impact is a result of flawed assumptions and ignores questionable cost-effectiveness for RSV prophylaxis.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
13(5)
[DOI] 10.1111/j.1524-4733.2010.00723.x.
[PMID] 20412545.
2009
Cost-Effectiveness of Respiratory Syncytial Virus Prophylaxis With Palivizumab From the Perspective of a Southern Us Medicaid Agency
Value in Health.
12(7):A301-A302
[DOI] 10.1016/S1098-3015(10)74479-X.
2009
Seasonal Versus Needs-Based Immunization Schedules-the Example of Rsv
Value in Health.
12(7)
[DOI] 10.1016/S1098-3015(10)74509-5.
2009
Validation of the National Respiratory and Enteric Virus Surveillance System for the Detection of Respiratory Syncytial Virus Seasons
Pharmacoepidemiology and Drug Safety.
18
2008
Cost-utility analysis of rimonabant in the treatment of obesity.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
11(3):389-99
[DOI] 10.1111/j.1524-4733.2007.00281.x.
[PMID] 18179661.
2008
Erythropoiesis-Stimulating Agent Exposure and Incidence of Venous Thromboembolism in High-Risk Trauma Patients Receiving Enoxaparin.
Critical Care Medicine.
36
2008
Palivizumab Utilization and Compliance With Recommendations in Florida
Pharmacoepidemiology and Drug Safety.
17
2008
Response to respiratory synctial virus.
Southern medical journal.
101(2):212-3; author reply 213
[DOI] 10.1097/SMJ.0b013e3181611d5f.
[PMID] 18364631.
2008
Role of Age in Respiratory Syncycial Virus Infection Risk – Recommendations for Palivizumab Utilization
Pharmacoepidemiology and Drug Safety.
17
Contact Details
Phones:
- Business:
- (352) 273-6248
Emails:
- Business:
- champp@ufl.edu
Addresses:
- Business Mailing:
-
PO Box 100496
GAINESVILLE FL 32610 - Business Street:
-
101 NEWELL DR
GAINESVILLE FL 32611